Literature DB >> 33682062

Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.

Ryusuke Ae1, Hiroya Masuda2, Taka-Aki Koshimizu3, Masami Matsumura4, Koki Kosami2, Kanako Hayashida2, Nobuko Makino2, Yuri Matsubara2, Teppei Sasahara2, Yosikazu Nakamura2.   

Abstract

A giant coronary artery (CA) aneurysm is a potentially fatal cardiac complication resulting from Kawasaki disease (KD). We aimed to identify epidemiologic characteristics and potential risk factors associated with giant CA aneurysms identified after acute KD. We analyzed 90,252 patients diagnosed with KD from 2011 to 2018, using data obtained in nationwide KD surveys conducted in Japan. Multivariable logistic regression analyses were performed to evaluate potential risk factors associated with subsequent giant CA aneurysm complications (defined as lumen size ≥ 8 mm), adjusting for all potential factors. Giant CA aneurysms were identified in 144 patients (0.16%) after acute KD. The annual prevalence ranged from 0.07 to 0.20% during the study period. In the multivariate analyses, male sex (adjusted odds ratio 2.09 [95% confidence interval 1.41-3.11], recurrent KD (1.90 [1.09-3.33]), IVIG administration at 1-4 days of illness (1.49 [1.04-2.15]) and ≥ 8 days after KD onset (2.52 [1.38-4.60]; reference, 5-7 days), detection of CA dilatations and aneurysms at initial echocardiography (4.17 [1.85-5.41] and 46.5 [28.8-74.8], respectively), and resistance to IVIG treatment (6.09 [4.23-8.75]) were significantly associated with giant CA aneurysm complications identified after acute KD. The annual prevalence of giant CA aneurysms identified after acute KD did not increase during the study period. Patients with larger CA abnormalities detected at initial echocardiography were independently associated with progression to giant CA aneurysm complications after acute KD regardless of the number of days from onset at treatment initiation.

Entities:  

Keywords:  Cardiac complication; Coronary artery abnormality; Coronary artery aneurysm; Coronary artery dilatation; Giant coronary artery aneurysm; Kawasaki disease

Year:  2021        PMID: 33682062     DOI: 10.1007/s00246-021-02571-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  25 in total

Review 1.  JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease.

Authors:  Ryuji Fukazawa; Junjiro Kobayashi; Mamoru Ayusawa; Hiromichi Hamada; Masaru Miura; Yoshihide Mitani; Etsuko Tsuda; Hiroyuki Nakajima; Hiroyuki Matsuura; Kazuyuki Ikeda; Kazuhiko Nishigaki; Hiroyuki Suzuki; Kei Takahashi; Kenji Suda; Hiroshi Kamiyama; Yoshihiro Onouchi; Tohru Kobayashi; Hiroyoshi Yokoi; Kisaburo Sakamoto; Masami Ochi; Soichiro Kitamura; Kenji Hamaoka; Hideaki Senzaki; Takeshi Kimura
Journal:  Circ J       Date:  2020-07-08       Impact factor: 2.993

2.  Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018.

Authors:  Ryusuke Ae; Nobuko Makino; Koki Kosami; Masanari Kuwabara; Yuri Matsubara; Yosikazu Nakamura
Journal:  J Pediatr       Date:  2020-05-23       Impact factor: 4.406

Review 3.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

4.  Update of the epidemiology of Kawasaki disease in Japan--from the results of 1993-94 nationwide survey.

Authors:  H Yanagawa; Y Nakamura; M Yashiro; T Ojima; H Koyanagi; T Kawasaki
Journal:  J Epidemiol       Date:  1996-09       Impact factor: 3.211

5.  Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992.

Authors:  H Yanagawa; M Yashiro; Y Nakamura; T Kawasaki; H Kato
Journal:  Pediatrics       Date:  1995-04       Impact factor: 7.124

6.  Nationwide Survey of Patients With Giant Coronary Aneurysm Secondary to Kawasaki Disease 1999-2010 in Japan.

Authors:  Ryuji Fukazawa; Tohru Kobayashi; Masashi Mikami; Tsutomu Saji; Kenji Hamaoka; Hitoshi Kato; Hiroyuki Suzuki; Etsuko Tsuda; Mamoru Ayusawa; Masaru Miura; Ryota Ebata; Tomio Kobayashi; Mayumi Yashiro; Shunichi Ogawa
Journal:  Circ J       Date:  2017-08-30       Impact factor: 2.993

7.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

Review 8.  Kawasaki syndrome.

Authors:  Jane C Burns; Mary P Glodé
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

9.  Sudden Death as a Sequel of Ruptured Giant Coronary Artery Aneurysm in Kawasaki Disease.

Authors:  Jixiu Zhang; Talafu Tuokan; Yonghua Shi
Journal:  Am J Forensic Med Pathol       Date:  2018-12       Impact factor: 0.921

10.  Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey.

Authors:  Nobuko Makino; Yosikazu Nakamura; Mayumi Yashiro; Ryusuke Ae; Satoshi Tsuboi; Yasuko Aoyama; Takao Kojo; Ritei Uehara; Kazuhiko Kotani; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2015-02-07       Impact factor: 3.211

View more
  3 in total

1.  Myocardial Infarction in Children after COVID-19 and Risk Factors for Thrombosis.

Authors:  Eliza Cinteză; Cristiana Voicu; Cristina Filip; Mihnea Ioniță; Monica Popescu; Mihaela Bălgrădean; Alin Nicolescu; Hiyam Mahmoud
Journal:  Diagnostics (Basel)       Date:  2022-04-01

Review 2.  Neutrophil to Lymphocyte Ratio as a Biomarker for Predicting the Coronary Artery Abnormality in Kawasaki Disease: A Meta-Analysis.

Authors:  Shirin Sarejloo; Matin Moallem Shahri; Pouria Azami; Alec Clark; Ethan Hass; Maryam Salimi; Brandon Lucke-Wold; Shahram Sadeghvand; Shokoufeh Khanzadeh
Journal:  Dis Markers       Date:  2022-10-11       Impact factor: 3.464

3.  Risk factors and coronary artery outcomes of coronary artery aneurysms differing in size and emergence time in children with Kawasaki disease.

Authors:  Jie Liu; Qiaoyu Yue; Suyuan Qin; Danyan Su; Bingbing Ye; Yusheng Pang
Journal:  Front Cardiovasc Med       Date:  2022-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.